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Abstract. Lately, several studies started to investigate the existence of links between 
cannabis use and psychotic disorders. This work proposes a refined Machine 
Learning framework for understanding the links between cannabis use and 1st 
episode psychosis. The novel framework concerns extracting predictive patterns 
from clinical data using optimised and post-processed models based on Gaussian 
Processes, Support Vector Machines, and Neural Networks algorithms. The 
cannabis use attributes’ predictive power is investigated, and we demonstrate 
statistically and with ROC analysis that their presence in the dataset enhances the 
prediction performance of the models with respect to models built on data without 
these specific attributes.  
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1. Introduction 
According to the World Health Organisation (WHO), eHealth is any secure, cheap, and 
efficient use of information and communications technologies in order to support health 
[1]. These days, more health care providers are replacing traditional paper notes with 
electronic patient records. In addition, the usage of advanced technologies such as 
computers, personal digital assistants, smart phones, etc. had enabled information to 
become more available and accurate. This lead to a tremendous increase in the electronic 
health data making an ideal promising land for applying machine learning algorithms to 
extract insights from data.  
Currently machine learning algorithms are in the process of revolutionizing health. 
In just the same way as machine learning has made an enormous difference to business 
and industry, it will just as undoubtedly enhance medical research, and improve the 
practice of healthcare providers. For instance, machine learning algorithms have been 
successfully used in understanding the different manifestations of asthma [2], diagnosing 
psychosis [3][4], classifying leukaemia [5], detecting heart conditions in 
electrocardiogram (ECG) data [6], etc. In particular, machine learning algorithms have 
been proven to be capable of dealing with complicated medical data such as ECG signal 
data, where they show some outstanding results compared to traditional statistical 
approaches.  
These studies suggest that machine learning can provide medical research with 
powerful techniques beyond the traditional statistical approaches mostly used, which 
include the conventional statistical tests, linear and logistic regression. Also, in 
biomedical engineering, several recent papers explored the potential for machine 
learning algorithms to detect various diseases. This has led to the publication of more 
guidance for medical researchers on how to infer and question such findings [7]. Finally, 
there is a tremendous interest in current interdisciplinary research into exploiting the 
power of machine learning to enable further progress in the new area of Precision 
Medicine, in which predictive modelling plays a vital role in forecasting treatment 
outcomes, and thus decisively contributes in optimising and personalising treatments for 
patients [8]. 
The medical field is considered as a critical area of research, yet there are still many 
difficult tasks that need to be carried out precisely and efficiently. The future success of 
health sector planning, and of healthcare in general, will be the adoption of intelligent 
systems where robotics and machine learning intersect. In order for health sector 
planning to catch up in this fast changing environment, machine learning must be put at 
the core of most strategies. For example, new developments in Psychiatry concern the so 
called Data-driven Computational Psychiatry, which relies heavily on the use of machine 
learning.   
In this study, we propose a new computational psychiatry and machine learning 
framework based on developing optimised models for predicting the onset of ﬁrst-
episode psychosis with Gaussian Processes (GP), Support Vector Machines (SVM), and 
Neural Networks (NNET). In particular, our aim is the predictive modelling approach to 
help understanding the link between the first-episode psychosis and cannabis use.  The 
dataset on which we based our study was collected by psychiatry practitioners and was 
used in previously conducted studies, such as [3][9]. It comprises an extensive set of 
variables, including demographic, drug-related and other variables, with specific 
information on participants' history of cannabis use - some of which being illustrated in 
Table 1.  
Table 1. Cannabis use attributes in the analysed dataset [3]. 
Attribute Description 
lifetime_cannabis_user Ever used cannabis: yes or no 
age_ﬁrst_cannabis Age upon ﬁrst use of cannabis: 7 to 50 
age_ﬁrst_cannabis_under15 
 Age less than 15 when ﬁrst used cannabis: yes, no or never used 
age_ﬁrst_cannabis_under14 
 Age less than 14 when ﬁrst used cannabis: yes, no or never used 
current_cannabis_user Current cannabis user: yes or no 




Cannabis usage measure: none, hash less than once per week, hash 
on weekends, hash daily, skunk less than once per week, skunk on 
weekends, skunk daily 
cannabis_type Cannabis type: never used, hash or skunk 
duration Cannabis use duration: 0 to 41 (months) 
The framework we present here integrates: data pre-processing, model tuning, model 
post-processing with receiver operating characteristic (ROC) optimisation based on the 
maximum accuracy cut-off threshold, and model evaluation with k-fold cross-testing. 
This sequence of enumerated phases is repeated 500 times for each GP, SVM with radial 
and polynomial kernels, and NNET algorithms, to study the potential variation of the 
performances of the resulting models. We investigated also the cannabis use attributes’ 
predictive power by establishing statistically that their presence in the dataset augments 
the models’ performances.  
2. Methods 
2.1. Description of study population  
The data we used to build our predictive models were a part of a case-control study [9]. 
The clinical data comprise 1106 records divided into 489 patients, 370 controls and 247 
unlabelled records. The patients were individuals who presented with first-episode 
psychosis to the inpatient units of the South London & Maudsley Mental Health National 
Health Service (NHS) Foundation Trust. The controls were healthy people recruited from 
the same area served by the Trust. Each record in the data refers to a participant in the 
study and has 255 possible attributes divided into four groups. The first group consists 
of demographic attributes, which represent general features like gender, race and level 
of education. The second group of drug-related attributes contains information on the use 
of non-cannabis drugs, such as tobacco, stimulants and alcohol. The third group contains 
genetic attributes. These were removed from the analysis since they were out of this 
study scope. The final group contains cannabis-related attributes, such as the duration of 
use, initial date of use, frequency, cannabis type, etc. 
For the purpose of building prediction models, we first removed any attribute with 
more than 50% missing value. Then, we perform the same high-level simpliﬁcation of 
the dataset that was proposed in [3]. The resulting dataset, after the transformations, 
contained 783 records and 78 attributes. The records are divided into 451 patients and 
332 controls. A summary of some of these ﬁelds—speciﬁcally, those that relate to 
cannabis use, such as type, age of ﬁrst use and duration—can be seen in Table 1. 
2.2. Data pre-processing  
The quality of data may signiﬁcantly affect the performance of the predictive models 
[10]. In order to help improve the quality of the data and, consequently, of the predictive 
models, the clinical data is pre-processed. Data pre-processing usually deals with the 
preparation and transformation of the initial dataset. In this study, we applied numerous 
pre-processing techniques such as missing values imputation, class balancing and feature 
selection to improve the efficiency and ease the modelling process. 
Firstly, in term of missing values imputation, we applied random forest imputation 
from the randomForest package [11]. Although this method is computationally 
expensive, it enhanced the predictive power of the final models.  
Secondly, the synthetic minority over-sampling technique (SMOTE) [12] was 
selected to treat the unbalanced classes existed in the data. SMOTE chooses a data point 
randomly from the minority class, de-terminus the K nearest neighbours to that point and 
then uses these neighbours to generate new synthetic data points using slight alterations. 
Our analysis used five neighbours. The results show that SMOTE leads to an increase in 
both the area under the ROC curve (AUC) and the accuracy. 
Finally, we applied a feature selection technique based on the information gain [13]. 
To do so, we evaluate the information gain for each attribute with respect to the class. 
Such techniques are often used with forward selection or backward elimination, which 
considers only removing the feature subset with least ranking values. In this study, we 
apply information gain to filter out the attribute that does not have predictive power 
regarding information gain. Figure 1 illustrates some (due to lack of space) attribute 
predictive power with respect to the information gain. Figure 1 shows that attributes such 
as riskcan and typefrq2, which are cannabis measures are the highest ranked attribute 
when attributes such as gender are among the least ranked attributes. Initially, this 
indicates that some of the cannabis use attributes have more productivity power than 
some of the demographic attributes 
 
Figure 1. Attributes’ predictive power with respect to Information Gain. 
2.3. Predictive modelling 
To develop optimised predictive models for first-episode psychosis, we controlled the 
values of the parameters for each of the considered algorithms using chosen grids. 
Predictive models have been fitted in a five-fold cross-validation procedure, on each 
training set after pre-processing techniques were applied on the same training set, and 
have been tested on each test set. Models based on SVM, NNET, and GP were optimised 
to maximise AUC.  
First, SVM models were tuned with different kernels such as SVM with the radial 
kernel (SVMR) and SVM with the polynomial kernel (SVMP). The optimal SVM 
models were obtained with SVMR, after tuning the parameters cost and gamma over 10 
values. The optimal values for cost and gamma were 16 and 0.004, respectively.  
Then, GP models were tuned with different kernels such as GP with the radial kernel 
(GPR) and GP with the polynomial kernel (GPP). The optimal GP models were obtained 
with GPP, with the parameters degree and scale, tuned over 10 values. The optimal 
values for degree and cost were 3 and 0.01, respectively.  
Finally, NNET models were tuned over 15 values for the size (i.e. the number of 
hidden units) and 15 values for the decay (i.e. the weight decay), which is the parameter 
in the penalisation method for model regularisation. The optimal values were 13 and 
0.01, respectively. 
2.4. Predictive model post-processing  
ROC curves allow visual analyses of the trade-offs between a predictive model’s 
sensitivity and specificity regarding various probability cut-offs. The curve is obtained 
by measuring the sensitivity and specificity of the predictive model at every cutting point 
and plotting the sensitivity against 1-specificity. Figure 2 shows the ROC curves 
obtained for three of our predictive models, which are SVMR, NNET and GPR. The 




Figure 2. ROC curves for 3 models: SVMR, NNET and GPR. 
Several methods exist for finding a new cut-oﬀ threshold on the ROC curve. In this 
study, we find the point on the ROC curve corresponding to the highest accuracy.  
2.5. Overall modelling procedure  
The overall modelling procedure, which is based on data pre-processing, model 
optimisation, model post-processing and model evaluation, is inspired by [4] and 
reformulated and adapted to the context of the present framework. First, the dataset is 
randomly split, with stratification, in 60% and 40% parts denoted here by P1 and P2, 
respectively. Then, P1 is used for training and for optimising the model, as explained in 
Subsection 2.3. Different pre-processing methods that were explained in Subsection 2.2 
were appropriately integrated into the cross-validation. Finally, in order to further 
enhance the model performance, the post-processing and model evaluation methods were 
applied to the optimised model using k-fold cross testing on the P2 dataset. In the k-fold 
cross testing procedure, we produce k post-processed model variants of the original 
optimised model. First, we create k stratified folds of the P2 dataset. Then, k-1 folds are 
used to find an alternative probability cut-off, that corresponds to the highest accuracy, 
on the ROC curve. The remaining one-fold is scored with the post-processed model 
based on the newly found cut-off point. This procedure enhances the predictive models 
and ensures that the datasets for post-processing and scoring are always distinct.  
3. Results 
Due to expected potential variations of the predictive models' performance, we 
conducted extensive repeated experiments simulations to study these variations and the 
models’ stability. The simulations consisted of 500 iterations of the procedure explained 
in Subsection 2.5. The models' performances concerning accuracy, AUC, sensitivity and 
specificity were evaluated for each iteration.  
The aggregation of all iterations yielded various distributions of the above 
performance measures. These distributions were then visualised using box plots in Figure 
3 to capture the models’ performance capability and stability.  
Also, estimations of the predictive neural networks’ performances regarding means 
and standard deviation (SD) are shown in Table 2. We report results regarding models 
which are post-processed with ROC optimisation based on the largest accuracy cut-off 
method, as explained in Subsection 2.5. The results show that SVMR achieved the best 
results with a mean accuracy of 0.83 (95% CI [0.79, 0.87]) and a mean sensitivity of 0.87 
(95% CI [0.81, 0.93]), similar to the results achieved by GPP.  The rest of the predictive 
models scored a mean accuracy of 81%, which is better than all performances scored at 
[3]. 
 
Figure 3. 500 repeated experiments simulations on Support Vector Machines with Radial (SVMR) and 
Polynomial kernels (SVMP), Gaussian Processes with Radial (GPR) and Polynomial kernels (GPR) and 
Single Layer Neural Networks (NNET). 
 
Overall, we find that the models, especially SVMR and GPP, have good predictive 
power and stability, based on an acceptable level of variation in their performance 
measures evaluated across extensive repeated experiments simulations. Also, the results 
indicate that the performance differences between the different methods for selecting the 
ROC cutting points are not significant regarding the 4 performances.    
 
Table 2. Estimations of the predictive model's performances. 
Model 
Accuracy AUC Sensitivity Specificity 
Mean SD mean SD mean SD mean SD 
SVMR 0.83 0.02 0.88 0.02 0.87 0.03 0.77 0.04 
SVMP 0.81 0.02 0.87 0.02 0.81 0.04 0.80 0.04 
NNET 0.81 0.02 0.86 0.03 0.81 0.04 0.80 0.04 
GPR 0.81 0.02 0.86 0.04 0.86 0.03 0.73 0.03 
GPP 0.83 0.02 0.89 0.02 0.88 0.03 0.77 0.04 
 
After performing the repeated experiments simulations, we further investigated the 
predictive models in order to better comprehend the predictive power of the cannabis-
related attributes over ﬁrst-episode psychosis via statistical tests. To do so, we re-ﬁt our 
performing models but removed the cannabis-related attributes, represented in Table 1, 
from the dataset. Then, we compared the performances of the models built with and 
without the cannabis-related attributes using t-test. We thereby demonstrated the 
predictive value of cannabis-related attributes with respect to ﬁrst-episode psychosis by 
showing that there is a statistically signiﬁcant difference between the performances of 
the predictive models built with and without the cannabis variables. 
 
Figure 4. Left: ROC curves for optimised SVMR, with and without the cannabis attributes. Right: boxplots 
for 500 repeated experiments simulations for optimised SVMR, with and without the cannabis attributes. 
 
Our analysis showed that the accuracy of SVMR decreased by 6% if the cannabis-
related attributes were dropped from the process of building the predictive models as 
shown in the right image in Figure 4. If we compare, for instance, the accuracies of the 
SVMR models built on the data sets with and without the cannabis use attributes, the p-
value obtained for the one-tailed t-test was 0.0002. This means that the predictive models 
with cannabis attributes have higher predictive accuracy than the models that were built 
without the cannabis attributes. This leads us to conclude that the additional cannabis 
variables jointly account for predictive information over ﬁrst-episode psychosis. These 
results are consistent with ﬁndings from [3]. Also, we demonstrated that there is a 
signiﬁcant difference between the ROC curves of the predictive models built with and 
without the cannabis variables as shown in the lift image in Figure 4. This also confirms 
the idea that the predictive models with cannabis attributes have higher predictive power 
than the models that were built without the cannabis attributes.  
4. Conclusion 
The advent of machine learning has so far proved to be of prime importance and 
capability in various fields, and recently in medical research and healthcare. This paper 
proposes a novel computational psychiatry and machine learning framework based on 
developping predictive models for the onset of first-episode psychosis in presence of 
clinical data including also cannabis use. We explored three types of machine learning 
algorithms, namely Gaussian Processes, Support Vector Machines, and feed-forward 
neural networks. Models are tuned and further optimised via post-processing, and 
evaluated with a k-fold cross testing methodology. In order to study the variation of the 
performances of the prediction models, the framework incorporates 500 repetitions of 
the model building, optimising, testing sequence. Experimental results show that the 3 
machine learning algorithms lead to comparable models, with a slight advantage for 
Support Vector Machines and Gaussian Processes in front of neural networks.  
Our best models score an average accuracy of 83%, which is above all the accuracy 
performances achieved in previous studies such as [3]. This paper extends on previous 
work as [3] by proposing a new machine learning framework based on a novel 
methodology in which models are post-processed based on ROC optimisation, and 
evaluated with the recent method of k-fold cross testing which we adapt after [4]. 
Moreover, in this new methodology, we developed optimized models with other 
powerful techniques such as Gaussian Processes and artificial neural networks not 
addressed in [3].  We also demonstrate statistically that the best models’ performance 
decreases if cannabis attributes are removed from the analysis. This fact is also confirmed 
and illustrated by ROC analysis.  
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